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Abstract
Dynamic covalent chemistry uses reversible chemical reactions to set up an equilibrating network
of molecules at thermodynamic equilibrium, which can adjust its composition in response to any
agent capable of altering the free energy of the system. When the target is a biological
macromolecule, such as a protein, the process corresponds to the protein directing the synthesis of
its own best ligand. Here, we demonstrate that reversible acylhydrazone formation is an effective
chemistry for biological dynamic combinatorial library formation. In the presence of aniline as a
nucleophilic catalyst, dynamic combinatorial libraries equilibrate rapidly at pH 6.2, are fully
reversible, and may be switched on or off by means of a change in pH. We have interfaced these
hydrazone dynamic combinatorial libraries with two isozymes from the glutathione S-transferase
class of enzyme, and observed divergent amplification effects, where each protein selects the best-
fitting hydrazone for the hydrophobic region of its active site.
Dynamic covalent chemistry (DCC) uses reversible chemical reactions to set up
equilibrating assemblies of molecules at thermodynamic equilibrium1-4. The resultant
dynamic combinatorial library (DCL) is responsive to the addition of a template, which will
selectively amplify the best binding compounds from the equilibrium distribution. The
essence of the concept lies in the subsequent adjustment of the DCL equilibrium, which will
express more of the best binding compounds at the expense of the poorer ones. A DCL is
thus adaptive and capable of evolutionary behaviour, whereby individual components are
either amplified or reduced in response to template-directed binding events. These concepts
have been applied to diverse problems in biological and medicinal chemistry5-11, synthetic
receptor–ligand interactions12-16, self-replication17-19, complex molecule synthesis20-22 and
materials science23,24. Taken together, they represent the best characterized examples to
date of systems chemistry, which looks to synthesize complex molecular networks and study
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their properties and behaviour in macrocosm, rather than as a sum of their individual
components25,26.
We are interested in DCC systems that use a biological molecule, such as a protein, to
template assemblies of small molecules at dynamic equilibrium27. Here, the DCC
experiment provides a method for discovering, studying and ranking novel protein ligands,
concepts fundamental to medicinal chemistry. In these terms, the DCC process bridges the
gap between targeted chemical synthesis of drug candidates and their biological binding
assay, meshing the two processes into a single step in which the structure of the biological
target directs the assembly of its own best inhibitor in situ.
A particular challenge for DCC in biological systems lies in the implementation of a suitable
reversible reaction that can operate effectively under the physiological conditions required
by the biotemplate. Lehn has defined two limiting cases for DCL construction: adaptive and
pre-equilibrated DCC28. The adaptive DCL represents the ideal scenario, where the DCL
chemistry is fully compatible with the biological target and the ensuing binding events
control the evolution of the DCL composition. Pre-equilibrated DCL refers to the cases
where the reversible chemistry used to constitute the DCL is not compatible with the
biological target, meaning that the DCL and the target must be separated in some manner.
This results in static libraries in which the molecular recognition events that control DCL
composition are lost. Given the challenges associated with conducting fast, freely reversible
chemistry under physiological conditions, it is not surprising that methods for true adaptive
DCL generation are limited, with the majority of successful systems using sulfur-based
transformations such as disulfide bond formation or thiol conjugate addition29-32. The
development of new methods for adaptive DCLs is thus central to the application of DCC to
biological systems, as the chemistry will define the target scope and range of available DCL
components.
The reversible formation of C=N imine-type linkages emerged early on as a DCL-forming
reaction33. The ready availability of diverse carbonyl and amine building blocks, plus the
extensive precedent of imine formation in biochemical systems, makes it an ideal candidate
reaction. However, the inherent instability of imines in aqueous solution presents serious
analytical and isolation problems in the DCC context. The solution to this in the field of
biological DCC has been to construct pseudo-adaptive DCLs where the imine linkage is
reduced in situ to an amine with an external hydride source. The resulting library contains
static amine components that can correspond to the imines in binding affinity, although both
false-positive and false-negative results are possible. In addition, the introduction of an in
situ reduction step complicates the DCL equilibration and makes it difficult to distinguish
between genuine thermodynamic selection of the best binders and selection of those
compounds that are kinetically favoured.
An advance on simple imine formation in DCC came from the Sanders group, who
introduced acylhydrazones as reversible linkages34. The reaction has proven to be an
excellent balance between facile reversibility and product stability; the acylhydrazone
products formed are stable to analysis and isolation, and the reaction has very good
equilibration properties, as is made evident by its application to a large number of elegant
abiological DCC studies subsequently reported by the Sanders group35-37. It has not,
however, been generally possible to apply this reaction directly to adaptive biological DCC
systems because of the acidic pH required for reversibility to occur in a reasonable
timeframe (pH < 4)38,39. A single elegant study from Poulsen has shown that slow
equilibration of acylhydrazones, taking one week at pH 7.2, can be accelerated in the
presence of the enzyme carbonic anhydrase, enabling in situ identification of binders using
mass spectrometry40. We were keen to apply this proven reaction to our DCC studies of
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enzymes, and reasoned that it could be harnessed as a powerful tool for biological
investigation if a suitable catalyst could be found to accelerate the equilibration.
Nucleophilic catalysis of semicarbazone formation using aniline derivatives was established
in classic work from Jencks in the 1960s, and recently applied to hydrazone and oxime
formation in peptide ligation systems by Dawson41-44. We reasoned that an additive such as
aniline could promote the equilibration of acylhydrazides and aldehydes at pH values closer
to the physiological window required by biological targets in DCC (Fig. 1).
We began by reacting aldehyde 1 (Fig. 2), related to the known glutathione S-transferase
(GST) substrate chlorodinitrobenzene (CDNB, see below), with an excess of the ten aryl
hydrazides 2a–2j at room temperature. The hydrazides were chosen to randomly display aryl
and heteroaryl groups and featured eight acyl and two sulfonyl hydrazides (2d and j).
Equilibration at pH 6.2 was slow, and only two of the ten possible hydrazones could be
observed by high-performance liquid chromatography (HPLC) after 1 h (Fig. 2c). Notably,
there was a significant amount of free aldehyde 1 present throughout the reaction, despite
the presence of excess amounts of the ten different hydrazides. Equilibrium was not
complete after 48 h, and required incubation for a further 5 days until the library
composition reached a steady-state composition with signals for each of the ten hydrazones
3a–3j being clearly identified. In contrast, repeating the experiment in the presence of
excess aniline produced a far higher rate of equilibration. A distribution of acylhydrazones
was observed after initial mixing and HPLC sampling, and complete equilibration of the ten
components was observed after just 6 h (Fig. 2d). Aldehyde 1 could not be detected
following initial mixing, indicating that it was continually being sequestered as an
acylhydrazone component, reflecting the faster exchange processes operating in the presence
of aniline (see Supplementary Information for a study on the effect of varying aniline
concentration on rates of hydrazone formation). We demonstrated the reversibility of the
DCL by generating it from a different starting composition, hydrazone 3g plus the nine other
hydrazides and aniline. An identical equilibrium distribution to Fig. 2 was observed,
indicating true thermodynamic equilibrium. A second control experiment confirmed the
reversibility of the DCL through the addition of excess hydrazide 2b to the preequilibrated
DCL, which resulted in a large amplification of the corresponding acylhydrazone 3b (see
Supplementary Information).
Having established that aniline could act as an effective nucleophilic catalyst for hydrazone
DCC formation at both a pH and timeframe reasonable for biomolecule stability, our next
step was to introduce proteins to the DCL. Our target chosen for DCC interrogation was the
GST enzyme superfamily45. The GSTs are responsible for cell detoxification, catalysing the
conjugation of glutathione (GSH) to a wide variety of xenobiotic electrophiles, thereby
protecting the cell from cytotoxic and oxidative stress. We have previously developed thiol
conjugate addition DCLs directed towards GST inhibition, and successfully interfaced the
enzyme with small molecules so that it controlled library evolution27. The GSTs are well
suited to exploration using DCC methods, being well-characterized, robust proteins having
nascent medicinal chemistry application46,47. There are relatively few ligands reported in
the literature for GST binding—a plus point, as it would enable us to use DCC as a genuine
discovery tool for new binding motifs, rather than as a proof-of-principle process for
confirming the binding ability of known ligands. The cytoplasmic GSTs are inherent dimers
with active sites composed of residues from both monomers, bifurcating between a highly
conserved G-site, which binds the endogenous ligand GSH, and an H-site, which binds
hydrophobic substrates for GSH conjugation (Fig. 3). This bisubstrate architecture is
particularly appropriate for DCC interrogation, given that the method essentially uses a
reversible linkage to couple two sets of fragment structures together48. Furthermore, within
the GST superfamily, the large, heterogeneous H-sites are functionally evolved to
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accommodate many different hydrophobic substrates for conjugation, a classically difficult
architecture to investigate using orthodox structure-based drug-design methods.
We prepared two recombinant GST isozymes as targets, SjGST from the helminth worm
Schistosoma japonicum, a drug target in tropical disease49, and hGST P1-1, a human
isoform that has been targeted in the treatment of chemotherapy drug resistance50. An initial
control experiment with SjGST established that the enzyme retained GSH conjugation
activity in the presence of aniline (up to 20 mM). The acylhydrazone DCL prepared in Fig. 2
was then interfaced with the two protein targets and amplification was measured (Fig. 4).
Both DCLs demonstrated strikingly clear amplification of hydrazone components; thiophene
acylhydrazone 3g was selected by SjGST and t-butylphenyl hydrazone 3c by hGST P1-1.
Synthesizing the DCL in the presence of bovine serum albumin (BSA, 1 equiv.) as a control
experiment produced no measurable amplification of any component, indicating the GST
enzymes as being responsible for component amplification. We further demonstrated that
amplified components were bound in the target H-region of the active site of the enzyme by
performing conjugation experiments with GSH. Conjugation of GSH to the aryl chloride
group in hydrazones 3 by means of SNAr substitution is a slow reaction at pH 6.2, taking
several days. In the presence of catalytic amounts of SjGST, however, rapid formation of the
SNAr conjugation adduct for hydrazone 3g was observed at pH 6.2. The amplified
hydrazone can thus act as a substrate for SjGST and binds in the targeted H-site.
The amplified hydrazones were re-synthesized and assayed against both GSTs and found to
be inhibitors of GSH conjugation of CDNB, but poor solubility prevented the determination
of accurate IC50 values at the higher concentrations necessary to assay weak binding
compounds. To solve this problem, and simultaneously increase the potency of our DCL
components, we conjugated GSH to aldehyde 1 using an SNAr reaction. We anticipated that
the highly soluble GSH tripeptide motif would act as an ‘anchor’ at the G-site, enabling
exploration of the H-site with assorted hydrazide fragments. This approach, in which a
known enzyme–substrate interaction is used for inhibitor discovery, is well exemplified in
classical medicinal chemistry drug design, GST inhibition51 and DCC methods. The IC50
value for SjGST inhibition of the anchored fragment 4 was measured in the CDNB
conjugation assay as 280 μM.
Initial DCC experiments using GS-conjugated aldehyde 4 and the same ten hydrazides used
previously confirmed the utility of aniline as a nucleophilic catalyst (Fig. 5). Equilibration
was complete in 6 h, compared to 4 days in the absence of aniline, and each of the ten
acylhydrazones were clearly identified by liquid chromatography-mass spectrometry (LC-
MS) (see Supplementary Information). As before, clear amplifications could be observed for
both GST targets: in each case the same hydrazide fragment was selected as the best binder,
thiophene (5g) for SjGST and t-butylphenyl (5c). Both components were amplified to over
300% of their concentrations in the blank DCL, at the expense of nearly all other competing
hydrazones. Also of note, the anisyl sulfonylhydrazone 5j underwent ~100% amplification
using hGST P1-1 as the only other positively selected component. The most significant
reductions in equilibrium concentrations occurred for 5b, f and i (SjGST) and 5f, g and i
(hGST P1-1).
The GST-directed DCLs were synthesized with the protein present from the beginning of the
experiment, that is, in the presence of aldehyde 4 and the ten hydrazides 2a–2j. To verify
that the amplification results were not due to a kinetic selection by means of target-
accelerated synthesis, we added SjGST to the pre-equilibrated DCL. The same equilibrium
distribution was achieved as is shown in Fig. 5, with hydrazone 5g strongly amplified,
indicating that the amplified components are the result of genuine thermodynamic selection.
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Further controls involved a BSA control experiment, which was negative, and DCL
synthesis in the presence of a large excess of the nonselective GST inhibitor ethacrynic acid.
Component amplification was completely suppressed for both SjGST and hGST P1-1 DCLs,
indicating that the GST active site is saturated by the ethacrynic acid and cannot influence
the DCL equilibrium composition.
We completed our protein-directed DCL studies by preparing a catalytically inactive SjGST
mutant. It was of interest to see whether a functionally disabled enzyme would exert the
same control and selectivity on DCL composition as the wild-type enzyme. The conserved
Tyr 7 active site residue is known to play a critical role in GSH conjugation for the Sj class
of GSTs, stabilizing the GSH thiolate anion through H-bonding from the phenol group, with
enzymes lacking this residue being catalytically inactive52. We prepared a Y7F mutant of
SjGST, in which the crucial tyrosine residue is replaced with phenylalanine. We observed
essentially zero activity with this mutant in CDNB conjugation when compared with the
wild-type SjGST. However, SjGST Y7F proved equally effective in controlling DCL
composition, showing a clear preference for the same thiophene derivative 5g as was
amplified by the wild-type SjGST (see Supplementary Information).
Biological assay was then performed to establish whether the best binding compounds in the
GST-directed DCLs were also the best inhibitors of the GST enzyme. To fully explore the
isozyme-specific amplification effects of the two DCLs, we separately synthesized
hydrazone conjugates 5a–5j for study. We first confirmed that the amplified ligands 5c and
5g bound to SjGST and hGST P1-1 by isothermal calorimetry (ITC) (see Supplementary
Information). We then studied their inhibitory activity towards SjGST and hGST P1-1 using
the CDNB conjugation assay. The IC50 values were slightly higher for all hydrazones
against hGST P1-1 compared to SjGST (data ranging from 59 to 126 μM and 22 to 63 μM,
respectively; see Supplementary Information). For each isozyme, the DCC amplified
hydrazone was the most active; thiophene 5g had the lowest IC50 value (22 μM) among all
the library members against SjGST, and t-butylphenyl 5c had the lowest value among the
four conjugates tested against hGST P1-1 (57 μM). The DCL hydrazone selection process
has successfully extended inhibitor structure in the GST H-site, increasing potencies by
sixfold for hGST P1-1 (331 to 57 μM ) and by over tenfold for SjGST (279 to 22 μM)
relative to the starting anchored aldehyde 4.
Steady-state kinetic studies on the two amplified DCL components 5c (hGST P1-1) and 5g
(SjGST) confirmed the expected competitive inhibition profile, with both compounds
binding to the GST active sites. It was interesting to note slightly higher Ki values for both
compounds when assayed against CDNB, a substrate for the H-site of the enzyme, relative
to the endogenous G-site ligand GSH. The affinity of the two hydrazone conjugates towards
both GST G-sites was relatively close (data ranging from 5.25 to 7.19 μM), as would be
expected for two compounds sharing a common GSH-tagged nitrobenzene fragment.
To obtain some molecular insight into the selectivity of our isozymes towards the two
hydrazone inhibitors 5c and g, we carried out a molecular modelling study. We surveyed the
available GST structures in the protein data bank (PDB) and retrieved those that contained a
bound GSH-based ligand. The binding sites of these structures, together with the bound
ligands, were aligned, and it became evident that the glutathione portions overlaid well,
being bound in very similar conformations in the G-sites (Fig. 6a). In contrast, the conjugate
parts of the various ligands showed great diversity in their conformations within the H-site,
an unsurprising result given the respective functions of the G- and H-sites. Detailed analysis
of the superimposed crystal structures identified the GSH conjugate of 1,2-epoxy-3-(p-
nitrophenoxy)propane (EPNP) (6) bound to cGST M1-1 (PDB code 1c72)53 as the ligand
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that projected functionality into the H-site with the most similar geometry to the energy-
minimized structure of hydrazone 5g (Fig. 6b).
Analysis of the GST–EPNP complex shows the EPNP moiety orienting towards R107 and
Q165 in the H-site of the enzyme (Fig. 7c). The side chains of R107, F110, Q165, Q166 and
F208 define the pocket that confines the EPNP moiety. On this basis, we could generate a
binding model for SjGST with thiophene hydrazone 5g and for hGST P1-1 with t-butyl
hydrazone 5c (Fig. 7). The interactions in the generated binding modes for SjGST in
complex with 5g (Fig. 7a) and for hGST P1-1 in complex with 5c (Fig. 7b) between the
glutathione moiety and the proteins are identical to those reported in previous
publications54,55. We predict that the hydrazone group of 5g forms hydrogen bonds to R103
and Q204 in SjGST, and equivalent interactions are observed for 5c in complex with hGST
P1-1. Residue V161 in SjGST and I161 in hGST P1-1 make hydrophobic interactions in our
models with the ligands 5c and 5g.
As expected, the sub-pockets of both isoforms accommodating the hydrazones are rather
hydrophobic, and complement the hydrophobic hydrazones amplified from the DCL. The
thiophene hydrazone fits easily in the SjGST binding pocket, with only minor sidechain
adjustments necessary (root mean square deviation (RMSD) 0.3 Å between model and
crystal structure template), whereas the t-butylphenyl group would lead to a steric clash and
would require some degree of induced fit in order to bind. Induced fit is also required to
accommodate this ligand in the hGST P1-1 pocket, but in that case the binding mode could
be stabilized by additional lipophilic interactions of the t-butyl group with Y103, H162 and
I161. It is worth noting that Chern and colleagues have reported that mutations in that region
of the H-site had a great impact on EPNP binding as a substrate, with mutation of cGST
M1-1 Q165 to leucine (V161 in SjGST and I161 in hGST P1-1) reducing kcatEPNP by 59%,
although Km showed only small changes53. Because the amino acids in the equivalent
pocket of SjGST and hGST P1-1 are not highly conserved, these residues have such a great
influence on ligand binding that it is likely that these amino-acid exchanges across the
isoforms are critical in determining ligand selectivity.
Conclusions
We have demonstrated that reversible synthesis of acylhydrazones can be compatible with
protein targets by using aniline as a nucleophilic catalyst. The many advantages of this DCC
tool (ready availability of easily customized building blocks, good kinetic and
thermodynamic properties leading to ease of analysis, good biological compatibility forming
amide-like linkages) may now be realized with biological targets. Most importantly, the
acylhydrazone DCLs are truly adaptive, allowing amplification effects to be simply and
directly related to structures present at equilibrium.
The GST enzyme proved extremely effective as a DCL template, with two isozymes from
the GST family smoothly integrating with the small molecule assemblies and strongly
amplifying the best binding components. The selected hydrazones showed increased
inhibitory activity of over one order of magnitude from the starting GSH-tagged
benzaldehyde 4, validating the approach in the context of protein–ligand discovery.
Interestingly, a single, small DCL composed of only ten members displays isozyme
selectivity according to which variant of the GST enzyme is used as the template.
The study at hand has been deliberately confined to a small number of DCL components so
as to thoroughly characterize equilibrium distributions and quantify amplifications with the
aniline-catalysed hydrazone method. In principle, much larger hydrazone DCLs may be
accessed to thoroughly explore chemical space, both within the GST H-site and for other
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biological targets9,15. It may not be possible, or even desirable, to accurately characterize
the equilibrium distribution of such complex DCLs, but this will not be necessary if one
simply seeks to identify prominently amplified components from a ligand discovery
perspective.
To gain insight into isoform selectivity, we found that each amplified molecule could be
effectively docked into its respective GST H-site, although the fine structural features of the
SjGST versus hGST P1-1 H-site that discriminate between thiophene hydrazone 5g and t-
butylphenyl hydrazone 5c are unclear at the present time. Structural determination of the
complexes of various GST:GS-hydrazone conjugates will be needed for a deeper
understanding of the factors that control H-site selectivity. Work in this area, together with
applications of acylhydrazone DCC to other biological targets, is the subject of our current
research.
Methods
Aniline catalysis of reversible hydrazone formation
The ten hydrazides 2a–j (10 × 5 μl, 10 mM, DMSO), aldehyde 1 (2 μl, 10 mM, DMSO) and
aniline (10 μl, 1 M, DMSO) were added to a mixture of DMSO (93 μl) and ammonium
acetate buffer (845 μl, 50 mM, pH 6.2). The DCL was allowed to stand at room temperature
with occasional shaking, and was monitored periodically by HPLC to establish the blank
composition until the relative populations of the hydrazones became constant. The pH of all
samples was raised to 8 by the addition of NaOH (15 μl, 1 M, aqueous). LC-MS verified
that each of the expected hydrazones was present in the DCL (HPLC conditions: column,
Luna 5 μ C18(2), 30 mm × 4.6 mm, and Luna 5 μ C18(2), 50 mm × 4.6 mm, in sequence;
flow rate, 1 ml min−1; wavelength, 254 nm; temperature, 23 °C; gradient, H2O/MeCN
(0.01% TFA) from 95% to 80% over 6 min, then to 45% over 30 min, and eventually to 5%
over 5 min) (Fig. 2d). The DCL was then re-synthesized in the absence of aniline, and the
HPLC traces at different time intervals were compared (Fig. 2c).
Templated DCL aldehyde 1
SjGST (111 μl, 180 μM, in potassium phosphate buffer 0.1 M, pH 6.8), the ten hydrazides
2a–j (10 × 5 μl, 10 mM, DMSO), aldehyde 1 (2 μl, 10 mM, DMSO) and aniline (10 μl, 1
M, DMSO) were added to a mixture of DMSO (93 μl) and ammonium acetate buffer (734
μl, 50 mM, pH 6.2). The DCL was allowed to stand at room temperature, with occasional
shaking, for 12 h. The pH of the sample was raised to 8 by the addition of NaOH (15 μl, 1
M, aqueous), and the protein was removed by ultrafiltration using a 10,000 MWCO filter
(Vivaspin). HPLC analysis was performed and the traces were compared with the blank
composition (HPLC conditions: column, Luna 5 μ C18(2), 30 mm × 4.6 mm, and Luna 5 μ
C18(2), 50 mm × 4.6 mm, in sequence; flow rate, 1 ml min−1; wavelength, 254 nm;
temperature, 23 °C; gradient H2O/MeCN (0.01% TFA) from 95% to 80% over 6 min, then
to 45% over 30 min, and eventually to 5% over 5 min).
DCL composition was identical, regardless of whether the SjGST was present from the
beginning or added after pre-equilibration, but equilibration took more than 24 h in the latter
case.
For the hGST P1-1 templated library, the ten hydrazides 2a–j (10 × 5 μl, 10 mM, DMSO),
aldehyde 1 (2 μl, 10 mM, DMSO), aniline (10 μl, 1 M, DMSO) and hGST P1-1 (100 μl,
200 μM, in potassium phosphate buffer 0.1 M, pH 6.8) were added to a mixture of DMSO
(93 μl) and ammonium acetate buffer (734 μl, 50 mM, pH 6.2). After equilibration for 12 h,
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the DCL was analysed using HPLC. Control experiments were performed using the same
equivalents of BSA in place of GST.
Conjugate DCLs
To establish the blank DCL composition, the ten hydrazides 2a–j (10 × 5 μl, 10 mM,
DMSO), aldehyde 5 (5 μl, 10 mM, aqueous) and aniline (10 μl, 1 M, DMSO) were added to
a mixture of DMSO (96 μl) and ammonium acetate buffer (839 μl, 50 mM, pH 6.2). The
DCL was allowed to stand at room temperature, with occasional shaking, and was monitored
periodically by HPLC to establish the blank composition until the relative populations of the
hydrazones became constant. The pH of all the samples was increased to 8 by the addition of
NaOH (15 μl, 1 M, aqueous). LC-MS verified that each of the expected hydrazones was
present in the DCL (Fig. 5) (HPLC conditions: column, Luna 5 μ C18(2), 50 mM × 4.6 mm,
and Luna 5 μ C18(2), 250 mm × 4.6 mm, in sequence; flow rate, 1 ml min−1; wavelength,
254 nm; temperature, 23 °C; gradient H2O/MeCN (0.01% TFA) from 95% to 5% over 40
min).
For re-synthesizing the DCL in the presence of the protein SjGST (278 μl, 180 μM, in
potassium phosphate buffer 0.1 M, pH 6.8), the ten hydrazides 2a–j (10 × 5 μl, 10 mM,
DMSO), aldehyde 5 (5 μl, 10 mM, DMSO) and aniline (10 μl, 1 M, DMSO) were added to
a mixture of DMSO (96 μl) and ammonium acetate buffer (561 μl, 50 mM, pH 6.2). The
DCL templated by hGST P1-1 was synthesized by adding the ten hydrazides 2a–j (10 × 5
μl, 10 mM, DMSO), aldehyde 5 (5 μl, 10 mM, DMSO), aniline (10 μl, 1 M, DMSO) and
hGST P1-1 (250 μl, 200 μM, in potassium phosphate buffer 0.1 M, pH 6.8) to a mixture of
DMSO (96 μl) and ammonium acetate buffer (589 μl, 50 mM, pH 6.2). The DCLs were
allowed to stand at room temperature for 12 h, after which the pH was raised to 8 by the
addition of NaOH (15 μl, 1 M). The protein was filtered off using a centrifuge filter of
MWCO 10,000 followed by analysis of the filtrate by HPLC using conditions similar to
those listed above.
Molecular modelling
To establish ligand alignment, the superposition of GST ligands was carried out using
Relibase + 3.0.0 (ref. 56). A search was first performed to find binding sites that share a
sequence identity between 40 and 100% with the target GST crystal structure 1m9a. The
resulting 38 structures with bound ligand were superimposed by using binding site residues
only. Finally, the ligands from the superimposed structures were extracted and visually
analysed.
To carry out a binding mode prediction with Moloc57, the SjGST crystal structure (PDB
code 1m9a SjGST - S-hexyl-GSH complex) and the hGST P1-1-GSH complex crystal
structure (PDB code 6gss)54 were used as starting conformations for binding mode
generation. The glutathione groups of the synthesized ligands were mapped onto the
glutathione groups of the ligands bound to the crystal structures. The hydrophobic
hydrazone groups of the synthesized ligands were oriented towards the cavity, lying at the
end of the S-hexyl site, as observed for the EPNP ligand bound to cGSTM1-1 (PDB code
1c72). In the next step, the protein in complex with the modelled ligand was minimized,
considering the ligand as fully flexible. For the protein all residues were kept rigid, except
for the amino acids that define the pocket at the end of the S-hexyl site (R103, V106, V161,
V162, Q204 for SjGST and R100, Y103, I161, H162, N204 for hGST P1-1).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Transimination reactions for DCC
a, Imine DCLs: reversible addition of amines to aldehydes gives unstable imines that cannot
be isolated or analysed directly, necessitating an in situ reduction step. The resultant static
library of amines may or may not share the binding profile of the imine precursors. b, Acyl
hydrazone DCLs: reaction of aldehydes with hydrazides gives acylhydrazones that have
good stability and are amenable to analysis. Equilibration requires acidic conditions that are
incompatible with biological targets—a nucleophilic catalyst such as aniline may enable
DCL formation at biocompatible pH.
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Figure 2. Aniline-catalysed acylhydrazone formation
a, Aldehyde equilibration with hydrazide to form an acylhydrazone. b, Hydrazide
components of the ten-membered DCL. c, DCL established in the absence of aniline.
Conditions: aldehyde (5 μM), hydrazides (20 μM each) in NH4OAc buffer (50 mM, pH 6.2)
containing 15% DMSO. d, DCL established in the presence of aniline (10 mM).
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Figure 3. Structure of GST illustrating H- and G-sites
Grey, monomer 1; yellow, monomer 2; green, G-site; red, H-site.
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Figure 4. GST-templated DCLs
a, DCL hydrazone composition in the absence of any target (blank). b, When the DCL is
constituted in the presence of SjGST, the thiophene hydrazone 3g is clearly amplified. c,
Changing the target protein to hGSTP1-1 produces a different distrubution, in which the t-
butylphenyl derivative 3c is amplified. Targeted DCL conditions: GST (1 equiv.), aldehyde
(5 μM), hydrazides (20 μM) and aniline (10 mM) in NH4OAc buffer (50 mM, pH = 6.2)
containing 15% DMSO for 16 h.
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Figure 5. GST-templated DCLs of GSH conjugates
a, Acyl hydrazone DCL based on GSH-conjugated aldehyde 4 (GS S-linked glutathione). b,
DCL hydrazone composition in the absence of target (blank), in the presence of SjGST and
in the presence of hGSTP1-1. DCL conditions: GST (1 equiv.), aldehyde (5 μM),
hydrazides (20 μM) and aniline (10 mM) in NH4OAc buffer (50 mM, pH = 6.2) containing
15% DMSO for 16 h. c, Changes in DCL component concentration for blank, SjGST and
hGST P1-1 DCLs. The error bars represent the standard deviation over three experiments.
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Figure 6. GST ligands
a, Superposition of a selection of GST ligands from the PDB. b, Conformation of the GST-
bound EPNP ligand 6 as found in the crystal structure of cGST M1-1 (PDB code 1c72,
green carbon atoms), relative to the energy-minimized structure of compound 5g (pink
carbon atoms).
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Figure 7. Molecular modelling of amplified DCL components with the GST active site
a, Model of 5g bound to SjGST. b, Model of 5c bound to hGST P1-1. The binding pocket
surfaces are shown in light blue and key amino acids as blue sticks. The ligands are
represented in salmon pink, with atoms coloured by type. Hydrogen bonds of the conjugated
ligand parts are shown as yellow dotted lines. c, The EPNP-cGST M1-1 crystal structure
(PDB code 1c72). The binding pocket surface is shown in raspberry pink and key amino
acids as red sticks. The ligand is represented in green, with atoms coloured by type.
Hydrogen bonds of the conjugated ligand parts are shown as yellow dotted lines.
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